Ping An Biomedical Co., Ltd. Cash Flow-to-Debt Ratio
Ping An Biomedical Co., Ltd. cash flow-to-debt ratio. Ping An Biomedical Co., Ltd. (PASW) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-6.43 Million could theoretically repay 0% of its total liabilities ($23.17 Million) in one year. Check Ping An Biomedical Co., Ltd. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ping An Biomedical Co., Ltd. (2021–2025)
Cash flow-to-debt ratio of Ping An Biomedical Co., Ltd. from 2021 to 2025. Historical debt coverage capacity for Ping An Biomedical Co., Ltd. across 5 annual periods. Check total reinvestment intensity of Ping An Biomedical Co., Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Ping An Biomedical Co., Ltd. Cash Flow-to-Debt Ratio by Year (2021–2025)
Ping An Biomedical Co., Ltd. cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Ping An Biomedical Co., Ltd.. For the full cash flow conversion analysis, see PASW operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-6.43 Million | $23.17 Million | ▼ -221.4% |
| 2024 | 0.23x | $14.63 Million | $64.04 Million | ▲ +421.9% |
| 2023 | -0.07x | $-6.08 Million | $85.70 Million | ▼ -126.0% |
| 2022 | 0.27x | $21.09 Million | $77.35 Million | ▲ +165.8% |
| 2021 | -0.41x | $-31.37 Million | $75.77 Million | — |